Ignite Creation Date:
2025-12-18 @ 8:36 AM
Ignite Modification Date:
2025-12-23 @ 9:49 PM
Study NCT ID:
NCT03246685
Status:
None
Last Update Posted:
2018-12-14 00:00:00
First Post:
2017-07-22 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD
Sponsor:
Organization:
Raw JSON
{}